Praesidium Investment Management Company’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.7M Buy
1,863,506
+678,232
+57% +$10.2M 6.14% 9
2025
Q4
$21.4M Buy
1,185,274
+915,821
+340% +$16.4M 3.96% 9
2025
Q3
$4.99M Buy
+269,453
New +$4.23M 0.97% 12

Other funds holding CLBT

Praesidium Investment Management Company's CLBT Position: Q1 2026 in Review

Praesidium Investment Management Company increased its Cellebrite (CLBT) stake by 57% in Q1 2026, buying an estimated $10.2M and bringing the position to 1,863,506 shares worth $25.7M. The position accounts for 6.14% of the portfolio, ranked #9.

Praesidium Investment Management Company first reported a position in CLBT in Q3 2025 and has held it in 3 quarters since. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Praesidium Investment Management Company held 1,863,506 shares of Cellebrite worth $25.7M as of Q1 2026.
  • Praesidium Investment Management Company bought 678,232 Cellebrite shares in Q1 2026, an estimated $10.2M.
  • Cellebrite made up 6.14% of Praesidium Investment Management Company's portfolio in Q1 2026, its #9 holding.
  • Praesidium Investment Management Company first reported a position in Cellebrite in Q3 2025 and has held it in 3 quarters since.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Praesidium Investment Management Company's 13F filing for Q1 2026, filed 15 May 2026.